SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-279214
Filing Date
2022-11-07
Accepted
2022-11-07 17:05:59
Documents
15
Period of Report
2022-11-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d380935d8k.htm   iXBRL 8-K 27436
2 EX-1.1 d380935dex11.htm EX-1.1 197578
3 EX-5.1 d380935dex51.htm EX-5.1 10545
7 GRAPHIC g380935sp53.jpg GRAPHIC 9812
  Complete submission text file 0001193125-22-279214.txt   420386

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bcab-20221104.xsd EX-101.SCH 2857
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcab-20221104_lab.xml EX-101.LAB 17236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcab-20221104_pre.xml EX-101.PRE 10813
9 EXTRACTED XBRL INSTANCE DOCUMENT d380935d8k_htm.xml XML 3219
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

IRS No.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39787 | Film No.: 221366327
SIC: 2836 Biological Products, (No Diagnostic Substances)